Lifecore Biomedical Inc. (LFCR) — Long-term Investment Intensity
Lifecore Biomedical Inc. (LFCR) has a Long-term Investment Intensity of 9.0% as of May 2021. Long-term investments of $45.10 Million represent 9.0% of total assets of $502.92 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check LFCR capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Lifecore Biomedical Inc. Long-term Investment Intensity (2019–2021)
This chart shows how Lifecore Biomedical Inc.'s Long-term Investment Intensity has evolved across 3 annual periods from 2019 to 2021. As of May 2021, the intensity stands at 9.0%, reflecting long-term investments of $45.10 Million against total assets of $502.92 Million USD. Explore how well can Lifecore Biomedical Inc. service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Lifecore Biomedical Inc. (2019–2021)
The table below presents the year-by-year Long-term Investment Intensity for Lifecore Biomedical Inc. from 2019 to 2021, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Lifecore Biomedical Inc. market cap and net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 9.0% | $45.10 Million | $502.92 Million | ▼ -1.5 pp |
| 2020 | 10.5% | $56.90 Million | $541.31 Million | ▼ -1.3 pp |
| 2019 | 11.8% | $61.10 Million | $519.09 Million | — |